Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Oramed Ltd.”

9 pharma patents match "Oramed Ltd." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "Oramed Ltd." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “Oramed Ltd.” · 30,257 patents in full index Clear search

  1. US 11660327

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  2. US 11395848

    Methods and compositions for treating diabetes

    Oramed Ltd. · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted
  3. US 10967051

    Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof

    Oramed Ltd. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  4. US 10933022

    Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same

    Oramed Ltd. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  5. US 10881714

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  6. US 10398762

    Methods and compositions for treating diabetes

    Oramed Ltd. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  7. US 10350162

    Methods and compositions for oral administration of exenatide

    Oramed Ltd. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  8. US 10342764

    Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same

    Oramed Ltd. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  9. US 10058593

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted